BackSenti Biosciences Overview

Senti Biosciences Receivables

Track Senti Biosciences's receivables ($170K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$172000.00
↑ 35.43% YoYΔ $45000.00 vs prior year quarter

Peer average

Loading

Senti Biosciences Receivables History

Loading

Senti Biosciences vs. peers: Receivables Comparison

Loading

Senti Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Senti Biosciences (SNTI) FAQ

Senti Biosciences posts a receivables of $170K as of March 2026. That compares with $130K in the prior-year period — up 35.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Senti Biosciences's receivables was $130K. The latest reading is $170K — a 35.4% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Senti Biosciences's financial statement story. At $170K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SNTI's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Senti Biosciences's other metric pages and overview cover the third.